OneOme
AcquiredMinneapolis, United States · $5.3M raised
- Headquarters
- Minneapolis
- Business Model
- B2B
- Website
- oneome.com
- Total Funding
- $5.3M
- Last Round
- $5.3M Extension RoundOct 2016
- Rounds
- 1
- Acquisition Date
- Nov 2025
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
OneOme is a precision-medicine company that brings pharmacogenomic testing and analytics into patient care. Its evidence-based tools help healthcare teams personalize medication decisions according to each patient's genetic profile, with the goals of improving outcomes and reducing costs. Co-founded by Mayo Clinic, the company combines laboratory testing with analytics and serves healthcare customers globally from Minneapolis.
Summary
OneOme is a Biotech company based in Minneapolis, United States. It has raised $5.3M in total across 1 round, most recently a $5.3M Extension Round in Oct 2016. Investors include Invenshure and Mayo Clinic.
Funding & Exit History
Nov 2025
Sign up to see all 2 events
Funding: Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oneome"><img src="https://indexed.vc/api/badge/company/oneome" alt="OneOme on Indexed.vc" width="260" height="76" /></a>